Matches in Wikidata for { <http://www.wikidata.org/entity/Q66394403> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q66394403 description "clinical trial" @default.
- Q66394403 description "ensayu clínicu" @default.
- Q66394403 description "klinisch onderzoek" @default.
- Q66394403 description "клінічне випробування" @default.
- Q66394403 name "Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus" @default.
- Q66394403 name "Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus" @default.
- Q66394403 type Item @default.
- Q66394403 label "Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus" @default.
- Q66394403 label "Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus" @default.
- Q66394403 prefLabel "Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus" @default.
- Q66394403 prefLabel "Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus" @default.
- Q66394403 P1050 Q66394403-A084AAFD-5A8D-4591-AC42-EE33BF85BECE @default.
- Q66394403 P1132 Q66394403-F58D9ED6-59C9-4B47-8706-B0C8CD119723 @default.
- Q66394403 P1476 Q66394403-BD1C32A8-576C-4690-B04B-60949429A288 @default.
- Q66394403 P17 Q66394403-21405BFD-27C2-4645-BD3F-D738954B0FF8 @default.
- Q66394403 P17 Q66394403-38B5138D-0B58-4ED6-A24F-FBFD278EB3C8 @default.
- Q66394403 P17 Q66394403-51E8A62A-152C-4401-9978-BC719E7250B6 @default.
- Q66394403 P17 Q66394403-6FB9BD17-93E6-4062-81C2-755D81106569 @default.
- Q66394403 P17 Q66394403-7019DD3E-D6CC-42E5-A4AB-9E3D33FF5899 @default.
- Q66394403 P17 Q66394403-83B95E4D-0B86-46C4-B16A-F2E4307FA634 @default.
- Q66394403 P17 Q66394403-8CEAB5FB-1CF3-43AD-BBC0-D33B9D6ECD30 @default.
- Q66394403 P17 Q66394403-B7F1A20D-727E-40EF-867E-E94F2BBB5B20 @default.
- Q66394403 P17 Q66394403-BB89C84A-72D6-49CA-9982-D216D07BF441 @default.
- Q66394403 P17 Q66394403-C6D86B35-FF1D-4182-B4BD-3B82EF98890C @default.
- Q66394403 P17 Q66394403-E72A9636-C65B-4CFD-AEFC-C043E3D7B4B8 @default.
- Q66394403 P17 Q66394403-F494237C-47B0-49F5-8A03-094041129AE8 @default.
- Q66394403 P1813 Q66394403-3307B81A-6D52-4F7B-AD26-D978A0D3D57B @default.
- Q66394403 P2899 Q66394403-16884661-2CB5-4ACE-A49A-BA13FA73DE3D @default.
- Q66394403 P3098 Q66394403-11BAFA2F-4171-4CAE-90F2-67CA1AA5E8D8 @default.
- Q66394403 P31 Q66394403-F97EF6F7-A51C-4365-8B69-BFDD4F17F61F @default.
- Q66394403 P4844 Q66394403-167E6309-D52C-45B2-A51E-EFCCA40782F8 @default.
- Q66394403 P580 Q66394403-81BFAB71-1273-4A3B-A385-5DF9C7CD6331 @default.
- Q66394403 P582 Q66394403-F592BE58-C200-4B26-885C-87F851708726 @default.
- Q66394403 P6099 Q66394403-17BEF5DC-5B9B-4BD0-ACF6-E837B01D6D2C @default.
- Q66394403 P8363 Q66394403-4C9BC73E-8E47-4752-B72D-A413A1FACAC1 @default.
- Q66394403 P1050 Q12206 @default.
- Q66394403 P1132 "+711" @default.
- Q66394403 P1476 "Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus" @default.
- Q66394403 P17 Q1183 @default.
- Q66394403 P17 Q17 @default.
- Q66394403 P17 Q183 @default.
- Q66394403 P17 Q211 @default.
- Q66394403 P17 Q212 @default.
- Q66394403 P17 Q214 @default.
- Q66394403 P17 Q224 @default.
- Q66394403 P17 Q258 @default.
- Q66394403 P17 Q28 @default.
- Q66394403 P17 Q30 @default.
- Q66394403 P17 Q36 @default.
- Q66394403 P17 Q878 @default.
- Q66394403 P1813 "PIONEER 4" @default.
- Q66394403 P2899 "+18" @default.
- Q66394403 P3098 "NCT02863419" @default.
- Q66394403 P31 Q30612 @default.
- Q66394403 P4844 Q2526479 @default.
- Q66394403 P580 "2016-08-10T00:00:00Z" @default.
- Q66394403 P582 "2017-08-19T00:00:00Z" @default.
- Q66394403 P6099 Q42824827 @default.
- Q66394403 P8363 Q78089383 @default.